Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Study ID
NCT00006115

Study type
Interventional

Study phase
Phase 2

Study status
Unknown status

Trial Acronym

Trial Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have metastatic colorectal cancer that has not responded to previous chemotherapy.

More informations

Trial Starting Date

Apr 30,1999

Requirements

Gender All
Minimum age 18 Years
Maximum age 80 Years

Enrollement Limit